Persistence Market Research Company
Customize Now Report Sample

CGRP Inhibitors Market Size, Share, Trends, Growth, and Regional Forecasts 2025 - 2032

CGRP Inhibitors Market by Drug Type (Monoclonal Antibodies, CGRP Antagonists), by Product Type (Acute(Abortive), Preventative), by Route of Administration (Oral, Injectable, Nasal), by Distribution Channel, Patient Demographics, Regional Analysis for 2025 - 2032

Market Growth and Regional Outlook Report by Persistence Market Research

PMRREP33710
2 Jun 2025 Healthcare
199 Pages

Table of Content

  1. Executive Summary
    1. Global CGRP Inhibitors Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2024 - 2032, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Regulatory Landscape
    2. Product Adoption Analysis
    3. List of Recent FDA-Approved CGRP Inhibitors
    4. Pipeline Assessment
    5. Prevalence of Migraine by Key Countries
    6. Reimbursement Scenario
    7. Value Chain Analysis
    8. Key Deals and Mergers
    9. PESTLE Analysis
    10. Porter’s Five Force Analysis
  4. Global CGRP Inhibitors Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2023
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2024-2032
    3. Global CGRP Inhibitors Market Outlook: Drug Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Drug Type, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2024 - 2032
        1. Monoclonal Antibodies
        2. CGRP Antagonists
      4. Market Attractiveness Analysis: Drug Type
    4. Global CGRP Inhibitors Market Outlook: Treatment Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Treatment Type, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2024 - 2032
        1. Acute (Abortive)
        2. Preventative
      4. Market Attractiveness Analysis: Treatment Type
    5. Global CGRP Inhibitors Market Outlook: Route of Administration
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2024 - 2032
        1. Oral
        2. Injectable
        3. Nasal
      4. Market Attractiveness Analysis: Route of Administration
    6. Global CGRP Inhibitors Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024 - 2032
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
    7. Global CGRP Inhibitors Market Outlook: Patient Demographics
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Patient Demographics, 2019 - 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Patient Demographics, 2024 - 2032
        1. Adult
        2. Geriatric
        3. Paediatric
      4. Market Attractiveness Analysis: Patient Demographics
  5. Global CGRP Inhibitors Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2023
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America CGRP Inhibitors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Drug Type
      3. By Treatment Type
      4. By Route of Administration
      5. By Distribution Channel
      6. By Patient Demographics
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. U.S.
      2. Canada
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2024 - 2032
      1. Monoclonal Antibodies
      2. CGRP Antagonists
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2024 - 2032
      1. Acute (Abortive)
      2. Preventative
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2024 - 2032
      1. Oral
      2. Injectable
      3. Nasal
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Patient Demographics, 2024 - 2032
      1. Adult
      2. Geriatric
      3. Paediatric
    9. Market Attractiveness Analysis
  7. Europe CGRP Inhibitors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Drug Type
      3. By Treatment Type
      4. By Route of Administration
      5. By Distribution Channel
      6. By Patient Demographics
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2024 - 2032
      1. Monoclonal Antibodies
      2. CGRP Antagonists
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2024 - 2032
      1. Acute (Abortive)
      2. Preventative
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2024 - 2032
      1. Oral
      2. Injectable
      3. Nasal
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Patient Demographics, 2024 - 2032
      1. Adult
      2. Geriatric
      3. Paediatric
    9. Market Attractiveness Analysis
  8. East Asia CGRP Inhibitors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Drug Type
      3. By Treatment Type
      4. By Route of Administration
      5. By Distribution Channel
      6. By Patient Demographics
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. China
      2. Japan
      3. South Korea
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2024 - 2032
      1. Monoclonal Antibodies
      2. CGRP Antagonists
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2024 - 2032
      1. Acute (Abortive)
      2. Preventative
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2024 - 2032
      1. Oral
      2. Injectable
      3. Nasal
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Patient Demographics, 2024 - 2032
      1. Adult
      2. Geriatric
      3. Paediatric
    9. Market Attractiveness Analysis
  9. South Asia & Oceania CGRP Inhibitors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Drug Type
      3. By Treatment Type
      4. By Route of Administration
      5. By Distribution Channel
      6. By Patient Demographics
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2024 - 2032
      1. Monoclonal Antibodies
      2. CGRP Antagonists
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2024 - 2032
      1. Acute (Abortive)
      2. Preventative
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2024 - 2032
      1. Oral
      2. Injectable
      3. Nasal
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Patient Demographics, 2024 - 2032
      1. Adult
      2. Geriatric
      3. Paediatric
    9. Market Attractiveness Analysis
  10. Latin America CGRP Inhibitors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Drug Type
      3. By Treatment Type
      4. By Route of Administration
      5. By Distribution Channel
      6. By Patient Demographics
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2024 - 2032
      1. Monoclonal Antibodies
      2. CGRP Antagonists
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2024 - 2032
      1. Acute (Abortive)
      2. Preventative
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2024 - 2032
      1. Oral
      2. Injectable
      3. Nasal
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Patient Demographics, 2024 - 2032
      1. Adult
      2. Geriatric
      3. Paediatric
    9. Market Attractiveness Analysis
  11. Middle East & Africa CGRP Inhibitors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
      1. By Country
      2. By Drug Type
      3. By Treatment Type
      4. By Route of Administration
      5. By Distribution Channel
      6. By Patient Demographics
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 - 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Type, 2024 - 2032
      1. Monoclonal Antibodies
      2. CGRP Antagonists
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2024 - 2032
      1. Acute (Abortive)
      2. Preventative
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2024 - 2032
      1. Oral
      2. Injectable
      3. Nasal
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Patient Demographics, 2024 - 2032
      1. Adult
      2. Geriatric
      3. Paediatric
    9. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. AbbVie Inc.
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Amgen Inc.
      3. Eli Lilly and Company
      4. Teva Pharmaceutical Industries Ltd.
      5. Pfizer Inc.
      6. Lundbeck A/S
      7. Novartis AG
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate